CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsHigh structural barrier to entry
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
4.50BCNY667.92M · vs all stocks (USD)
Trailing P/E
44.43xRevenue (TTM)
318.16MCNY47.18M · vs all stocks (USD)
Profit Margin
31.91%Beta
0.0630xvs all stocks
52-Week Change
-16.95%vs all stocks
Market Capitalization
4.50BCNY667.92M · vs all stocks (USD)
Enterprise Value
4.02BCNY596.39M · vs all stocks (USD)
Trailing P/E
44.43xPrice to Sales (TTM)
14.58xPrice to Book (MRQ)
4.15xEnterprise to Revenue
12.64xGross Margin
35.55%Profit Margin
31.91%Operating Margin
-6.57%Return on Assets (TTM)
-1.30%Return on Equity (TTM)
9.60%Revenue (TTM)
318.16MCNY47.18M · vs all stocks (USD)
Revenue per Share (TTM)
0.4300CNYUpdated Aug 19, 2026Quarterly Revenue Growth
-7.70%Gross Profit (TTM)
95.72MCNY14.19M · vs all stocks (USD)
EBITDA (TTM)
184.21MCNY27.32M · vs all stocks (USD)
Net Income (TTM)
101.52MCNY15.06M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-39.42%Operating Cash Flow (TTM)
15.12MCNY2.24M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-47.66MCNY-7.07M · vs all stocks (USD)
Payout Ratio
0.00%Revenue
323.14MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
216.14MCNYFY2025 · Dec 31, 2025Gross Profit
107.00MCNYFY2025 · Dec 31, 2025Operating Income
-12.24MCNY-1.82M · vs all stocks (USD)
Pre-tax Income
96.43MCNYFY2025 · Dec 31, 2025Income Tax Expense
124.51KCNYFY2025 · Dec 31, 2025Net Income
96.31MCNYFY2025 · Dec 31, 2025EBIT
131.14MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
184.21MCNYFY2025 · Dec 31, 2025Research & Development
15.47MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
43.98MCNYFY2025 · Dec 31, 2025Other Operating Expenses
5.58MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
8.74MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
34.70MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1300CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1300CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
740.83MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
740.83MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
96.31MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
139.04MCNYFY2025 · Dec 31, 2025Free Cash Flow
134.00MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
608.14MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
96.31MCNYFY2025 · Dec 31, 2025Other Non-cash Items
32.74MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
59.31MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-49.32MCNYFY2025 · Dec 31, 2025Capital Expenditures
-5.04MCNYFY2025 · Dec 31, 2025Net Acquisitions
174.78MCNYFY2025 · Dec 31, 2025Purchase of Investments
-60.00MCNYFY2025 · Dec 31, 2025Sale of Investments
62.29MCNYFY2025 · Dec 31, 2025Other Investing Activity
2.12MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
174.15MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-277.23MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-37.37MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-314.60MCNYFY2025 · Dec 31, 2025Shares Outstanding
745.67MSharesUpdated Aug 19, 2026Float Shares
597.75MSharesUpdated Aug 19, 2026% Held by Insiders
19.70%vs all stocks
% Held by Institutions
0.10%vs all stocks
Total Cash (MRQ)
616.52MCNY91.43M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.8270CNYUpdated Aug 19, 2026Total Debt (MRQ)
0.00CNYvs all stocks (USD)
Total Debt to Equity (MRQ)
0.00xCurrent Ratio (MRQ)
7.91xBook Value per Share (MRQ)
1.50CNYUpdated Aug 19, 2026Total Assets
1.28BCNY189.78M · vs all stocks (USD)
Total Current Assets
898.27MCNYFY2025 · Dec 31, 2025Total Liabilities
159.43MCNYFY2025 · Dec 31, 2025Total Non-current Assets
381.44MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
7.19MCNYFY2025 · Dec 31, 2025Total Current Liabilities
152.24MCNYFY2025 · Dec 31, 2025Cash
608.14MCNYFY2025 · Dec 31, 2025Cash Equivalents
10.58MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
618.72MCNYFY2025 · Dec 31, 2025Accounts Receivable
91.42MCNYFY2025 · Dec 31, 2025Inventory
107.25MCNYFY2025 · Dec 31, 2025Accounts Payable
103.97MCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.92MCNYFY2025 · Dec 31, 2025Common Stock (Book)
745.67MCNYFY2025 · Dec 31, 2025Retained Earnings
-1.69BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.12BCNY166.14M · vs all stocks (USD)
52-Week Low
4.41CNYUpdated Aug 19, 202652-Week High
9.41CNYUpdated Aug 19, 202652-Week Change
-16.95%vs all stocks
Beta
0.0630xvs all stocks
50-Day MA
5.29CNYUpdated Aug 19, 2026200-Day MA
6.65CNYUpdated Aug 19, 2026Avg 10-Day Volume
55.40MSharesUpdated Aug 19, 2026Avg 30-Day Volume
39.22MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.1400CNYUpdated Aug 19, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock valued?
Drawdown With FCF And Cash Backing
Well below its peak, with three years of positive free cash flow behind it.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 15,055,936.83Operating Cash Flow (USD, TTM): 2,242,691.664
Financial Health
High structural barrier to entryNotable
Barrier to Entry: 0.81
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Contec Medical Systems Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Qurient Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Tianjin Lisheng Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Newland Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tibet Duorui Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Henan Taloph Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Gyre Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
CorMedix Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
LivsMed Inc.
Tier 1ProductionApproval-Gated PipelineRule
Supriya Lifescience Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Shanghai Bright Power Semiconductor Co., Ltd.
1 interpretationDrawdown With FCF And Cash Backing
JSL S.A.
1 interpretationDrawdown With FCF And Cash Backing
Colgate-Palmolive (India) Ltd.
1 interpretationDrawdown With FCF And Cash Backing